ZLAB (Zai Lab) Price-to-Operating-Cash-Flow: (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ZLAB Zai Lab Ltd ZLAB
72 GF Score
Price $26.24
GF Value $28.45
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Zai Lab Price-to-Operating-Cash-Flow?

As of today (2026-09-07), Zai Lab's share price is $26.24. Zai Lab's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2026 was $-1.20. Hence, Zai Lab's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Zai Lab's Price-to-Operating-Cash-Flow or its related term are showing as below:

ZLAB's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 23.38
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Zai Lab's Cash Flow from Operations per share for the three months ended in Jun. 2026 was $-0.57. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2026 was $-1.20.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 28.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 18.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -16.50% per year.

During the past 11 years, Zai Lab's highest 3-Year average Operating Cash Flow per Share Growth Rate was 28.90% per year. The lowest was -99.60% per year. And the median was -16.05% per year.

Zai Lab Price-to-Operating-Cash-Flow Historical Data

* Premium members only.

The historical data trend for Zai Lab's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zai Lab Price-to-Operating-Cash-Flow Chart

Zai Lab Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Zai Lab Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ZLAB vs ALMS, ARQT, BEAM: Price-to-Operating-Cash-Flow Comparison

For the Biotechnology subindustry, Zai Lab's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zai Lab Price-to-Operating-Cash-Flow vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zai Lab's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Zai Lab's Price-to-Operating-Cash-Flow falls into.


ZLAB
72GF Score
Zai Lab Ltd ZLAB
Price-to-Operating-Cash-Flow is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zai Lab Price-to-Operating-Cash-Flow Calculation

Zai Lab's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=26.24/-1.202
=

Zai Lab's Share Price of today is $26.24.
Zai Lab's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.20.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Is Zai Lab (ZLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Zai Lab stock appears to be undervalued. The current stock price of $26.24 is trading 7.8% below its estimated GF Value™ of $28.45. GuruFocus considers Zai Lab to be Fairly Valued.

Key valuation signals for ZLAB:

  • Price-to-Operating-Cash-Flow:
  • GF Value™: $28.45 vs. price of $26.24 (7.8% below fair value)
  • GF Score™: 72/100 with 8 warning signs

No single metric tells the full story. See the ZLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zai Lab Business Description

Other Exchanges 09688:Hong Kong1ZLB:Germany
Address 899 Halei Road, Building B, Pudong, Shanghai, CHN, 201203
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
72GF Score

Get the complete analysis for ZLAB

Price-to-Operating-Cash-Flow is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.24
Price
$28.45
GF Value